Mayassa J Bou-Dargham

6PUBLICATIONS
4CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Innate immunityTissue engineeringTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 10, 2023
TCGA RNA-Seq and Tumor-Infiltrating Lymphocyte Imaging Data Reveal Cold Tumor Signatures of Invasive Ductal Carcinomas and Estrogen Receptor-Positive Human Breast Tumors.

Mayassa J Bou-Dargham, Linlin Sha, Drishty B Sarker

|Jun 13, 2022
c-Rel-dependent monocytes are potent immune suppressor cells in cancer.

Ting Li, Mayassa J Bou-Dargham, Norman Fultang

|Aug 09, 2020
Secretome analysis reveals upregulated granzyme B in human androgen-repressed prostate cancer cells with mesenchymal and invasive phenotype.

Mayassa J Bou-Dargham, Qing-Xiang Amy Sang

|Jun 20, 2020
Immune landscape of human prostate cancer: immune evasion mechanisms and biomarkers for personalized immunotherapy.

Mayassa J Bou-Dargham, Linlin Sha, Qing-Xiang Amy Sang

|May 24, 2020
TNFAIP8 controls murine intestinal stem cell homeostasis and regeneration by regulating microbiome-induced Akt signaling.

Jason R Goldsmith, Nina Spitofsky, Ali Zamani

|Dec 05, 2018
Subgrouping breast cancer patients based on immune evasion mechanisms unravels a high involvement of transforming growth factor-beta and decoy receptor 3.

Mayassa J Bou-Dargham, Yuhang Liu, Qing-Xiang Amy Sang

Pageof 1

Frequent Collaborators

2 joint publications

Qing-Xiang Amy Sang

1 joint publications

Jason R Goldsmith

1 joint publications

Hakon Hakonarson

1 joint publications

Drishty B Sarker